Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

24 Week Open Label, Single Arm Study of Colesevelam in High Risk South Asians With Suboptimal LDL-c Levels Despite Maximally Tolerated Statin Therapy

NCT02504736 is registered in ClinicalTrials.gov with Canadian Collaborative Research Network as lead sponsor.

NCT NCT02504736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02504736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
24 Week Open Label, Single Arm Study of Colesevelam in High Risk South Asians With Suboptimal LDL-c Levels Despite Maximally Tolerated Statin Therapy
Lead sponsor
Canadian Collaborative Research Network
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
February 28, 2018
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia